Shutanluo won the title of "BRICS Variety"
Release time:
2020-07-22
Shu Tan Luo won the title of "BRICS "
News 7# December 22 , 2019 Most Competitive Neurological Drug "BRICS " Selection Results Announced, shotan Luo (paroxetine hydrochloride tablets), the main product of Jianfeng Pharmaceutical, won the title of "BRICS " with 68869 votes.
This selection is jointly sponsored by the Medical Observer News and the National Medical Elite Club, with the participation and support of the China Medical Materials Association, the National Health Industry Enterprise Management Association, and the China Medical Quality Management Association. The purpose is to let consumers have more understanding of domestic nervous system drugs and make good products go to the market better. A total of 221 varieties participated in this activity. After online voting and evaluation by experts and industry media, 9 varieties finally won the title of "BRICS " .
Sultanro is a serotonin reuptake inhibitor, which can be used to treat depression, panic disorder, obsessive-compulsive disorder, generalized anxiety, social anxiety and post-traumatic stress disorder. It is currently the SSRI drug with the widest indication for anti-anxiety, and is also one of the core products of Peak Pharmaceutical. Compared with similar products, sultano has the advantages of wide indications, fast onset, recurrence prevention and high safety. It is a first-line drug for antidepressants and anxiety. In this selection, Shutanluo won the first place in the popular WeChat voting session and was unanimously approved by the evaluation experts. He achieved the first good result in the total score and successfully won the title of "BRICS " . The achievement of this honor will further expand the product awareness of the peak pharmaceutical industry and improve its market competitiveness. (Fang Wen Tong)
More information
On the afternoon of June 9, Peak Cable Company organized all employees to learn fire fighting knowledge and conducted fire fighting and emergency escape drills. Since June, the subordinate enterprises of the company have organized training, learning and drills related to production safety according to their own characteristics and combined with the actual work. Safety production month series of activities carried out in an orderly manner.
2022
06-13
Spike Postdoctoral Research Papers on International Frontier Journals
Recently, good news came from the postdoctoral workstation of Jianfeng Pharmaceutical. Under the guidance of workstation mentor Jiang Xiaomeng, associate researcher Yang Xiaoxiao has made new progress in the treatment of alcoholic liver disease. The relevant research results "Roxadustat, a hypoxia-inducible factor 1a activator, attenuates both long- and short-term alcohol induced alcoholic liver disease" were published in the internationally renowned academic journal "Frontiers in Pharmacology. This journal is a frontier journal in the field of international pharmacy, mainly publishing academic papers and information on basic and clinical pharmacology, medicinal chemistry, pharmacology and toxicology.
2022
06-01
Daye Peak QC Achievements Won the Third Prize of Huangshi City
On May 7, Huangshi City Quality Strong City Working Committee organized a 2022 QC Results Conference. The QC project of "Technical Transformation of Ore Limestone Batching System" of Daye Peak Cement Company won the third prize.
2022
06-01
On April 28, Dalian Commodity Exchange held an online working meeting to announce the results of the 2021 excellent delivery warehouse and delivery warehouse excellent futures personnel selection, peak international trading company won the 2021 "excellent designated delivery warehouse" title, futures commissioner Ruan Weihang won the "excellent futures personnel" title.
2022
06-01
Cranberry extract combination identification detection method won the invention patent
After cranberry extract products were included in the "Zhejiang Province Key High-tech Product Development Project Plan" in 2021, Jianfeng Health Technology Company recently obtained an invention patent for the identification and detection method of cranberry extract. This new combined identification and detection method developed by Jianfeng Health identifies whether catechin or procyanidin B2 is added in cranberry extract by thin layer analysis, and then detects the unique A- type procyanidin and its chromatographic distribution in cranberry extract by high performance liquid chromatography, so as to improve the accuracy of product judgment. The identification method has the characteristics of accurate results and short detection time, which is of great significance to standardize the cranberry extract market and promote the healthy development of the industry, and has been unanimously recognized by peers.
2022
05-20
Daye Peak Manufacturing Department Won the Title of "Worker Pioneer" in Hubei Province
A few days ago, the manufacturing department of Daye Peak Cement Company was awarded the title of "Worker Pioneer" by the Hubei Provincial Federation of Trade Unions. Daye Jianfeng Manufacturing Department not only continued to actively explore and achieved good results in energy saving and consumption reduction, technological transformation, product quality process control, and economic responsibility system to guide management, but also improved Daye Jianfeng's overall operation level and won Huangshi City The seventh "Mayor Quality Award" created conditions and was fully affirmed by government departments at all levels.
2022
05-20
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page